10/27/2023

Highlights of the 5th edition of HTID®, organized by HealthTech For Care, with key players from the European HealthTech ecosystem to support innovation in healthcare for all patients.

The HealthTech Innovation Days (HTID®) brought together 750 participants on October 24 and 25, and remotely on October 27, including researchers, public players, industry...
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required

You hereby consent to us (imprint) processing your data in accordance with the detailed explanation and information (see point 6. Registration for an event there). In particular, you consent to BioRegio STERN processing the personal data provided by you as part of the registration for an event. We use the data provided in the registration for your participation in the event, i.e. e.g. for keeping lists of participants (only used internally).
Giving consent is completely voluntary. You have the right to revoke your consent at any time. The revocation of consent does not affect the lawfulness of the processing carried out on the basis of the consent until the revocation. You can declare your revocation, for example, at our premises, by letter to BioRegio STERN Management GmbH, Friedrichstr. 10, 70174 Stuttgart, Germany, or by e-mail to info@bioregio-stern.de or fax to fax number 0711-870354-44.
You have the right to object to the processing of data that we process on the basis of a legitimate interest. *

* Without filling in or ticking the fields or boxes marked with an asterisk (" * "), your application is not complete and cannot be processed by us."

If you have any questions, please contact Dr. Margot Jehle: jehle@bioregio-stern.de

An error occurred and processing did not complete.
This field is required
This field is required
This field is required
This field is required
This field is required
This field is required

You hereby consent to us (imprint) processing your data in accordance with the detailed explanation and information (see point 6. Registration for an event there). In particular, you consent to BioRegio STERN processing the personal data provided by you as part of the registration for an event. We use the data provided in the registration for your participation in the event, i.e. e.g. for keeping lists of participants (only used internally).
Giving consent is completely voluntary. You have the right to revoke your consent at any time. The revocation of consent does not affect the lawfulness of the processing carried out on the basis of the consent until the revocation. You can declare your revocation, for example, at our premises, by letter to BioRegio STERN Management GmbH, Friedrichstr. 10, 70174 Stuttgart, Germany, or by e-mail to info@bioregio-stern.de or fax to fax number 0711-870354-44.
You have the right to object to the processing of data that we process on the basis of a legitimate interest. *

* Without filling in or ticking the fields or boxes marked with an asterisk (" * "), your application is not complete and cannot be processed by us."

If you have any questions, please contact Dr. Margot Jehle: jehle@bioregio-stern.de

An error occurred and processing did not complete.
10/17/2023

Thermoplastschaum aus dem 3D-Drucker

Das Fraunhofer ICT hat Thermoplastschäume mit sehr geringer Dichte entwickelt. Mittels 3D-Druck könnten daraus individuelle Leichtbauteile gefertigt werden. Weil es bisher problematisch war Schäume bei Additiven Produktionsverfahren einzusetzen, haben Forscher am Fraunhofer IPA eigens dafür eine Ver...
10/12/2023

Viren als zielgerichtete Therapeutika

Viren gelten als wichtige Werkzeuge zur Entwicklung neuer Therapeutika gegen Krebs- und Erbkrankheiten. Das Stuttgarter Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB erhält rund 25 Millionen Euro aus Landesmitteln, um in den nächsten fünf Jahren eine Außenstelle »Virus-basierte ...
10/25/2023

Einzigartiges Nasenmikrobiom

Studie zeigt individuelle Unterschiede in der Immunantwort der Nase. Forschende der Universität Tübingen geben neue Einblicke in die spezifische Antikörper-Reaktion von körpereigenem Immunglobulin A. Die Ergebnisse helfen die körpereigene Immunantwort besser zu verstehen.

10/27/2023

Ligninbeschichtung macht Geotextilien aus umweltfreundlichen Naturfasern haltbar

Textilien sind beim Tiefbau selbstverständlich: Sie stabilisieren Wasserschutzdämme, verhindern, dass schadstoffhaltige Abwässer von Abfalldeponien abfließen, erleichtern...
10/24/2023

Immatics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ACTengine® IMA203 TCR-T Monotherapy

RMAT designation granted by FDA CBER for IMA203 cell therapy in multiple PRAME-expressing tumors including cutaneous and uveal melanoma, ovarian cancer and other cancer t...
10/24/2023

Immatics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ACTengine® IMA203 TCR-T Monotherapy

RMAT designation granted by FDA CBER for IMA203 cell therapy in multiple PRAME-expressing tumors including cutaneous and uveal melanoma, ovarian cancer and other cancer t...